These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 30777521)

  • 1. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel aspects of epitope matching and practical application in kidney transplantation.
    Lim WH; Wong G; Heidt S; Claas FHJ
    Kidney Int; 2018 Feb; 93(2):314-324. PubMed ID: 29061333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies.
    Duquesnoy RJ; Marrari M
    Curr Opin Organ Transplant; 2009 Aug; 14(4):403-9. PubMed ID: 19417654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA epitope based matching for transplantation.
    Duquesnoy RJ
    Transpl Immunol; 2014 Jun; 31(1):1-6. PubMed ID: 24769079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA Epitope Matching in Kidney Transplantation: An Overview for the General Nephrologist.
    Sypek M; Kausman J; Holt S; Hughes P
    Am J Kidney Dis; 2018 May; 71(5):720-731. PubMed ID: 29246419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation.
    Duquesnoy RJ
    Curr Opin Immunol; 2008 Oct; 20(5):594-601. PubMed ID: 18655832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long and winding road towards epitope matching in clinical transplantation.
    Kramer CSM; Israeli M; Mulder A; Doxiadis IIN; Haasnoot GW; Heidt S; Claas FHJ
    Transpl Int; 2019 Jan; 32(1):16-24. PubMed ID: 30341790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.
    Bosch A; Llorente S; Diaz JA; Salgado G; López M; Boix F; López-Hernández R; González-Soriano MJ; Campillo JA; Moya-Quiles MR; Perez-Lopez N; Minguela A; Jimeno L; Alvarez-López MR; Muro M
    Hum Immunol; 2012 May; 73(5):522-5. PubMed ID: 22425738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA matching at the epitope level: the way to go.
    Duquesnoy RJ
    Clin Transpl; 2013; ():441-51. PubMed ID: 25095540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplanting Sensitized Kidney Transplant Patients With Equivalent Outcomes Utilizing Stringent HLA Crossmatching.
    Rohan VS; Taber DJ; Moussa O; Pilch NA; Denmark S; Meadows HB; McGillicuddy JW; Chavin KD; Baliga PK; Bratton CF
    Exp Clin Transplant; 2017 Feb; 15(1):47-55. PubMed ID: 27267614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical evaluation of a possible role of HLA epitope matching in kidney transplantation.
    Kumru Sahin G; Unterrainer C; Süsal C
    Transplant Rev (Orlando); 2020 Apr; 34(2):100533. PubMed ID: 32007300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens.
    Duquesnoy RJ; Marrari M
    Tissue Antigens; 2009 Aug; 74(2):117-33. PubMed ID: 19497041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope analysis of HLA-DQ antigens: what does the antibody see?
    Tambur AR; Rosati J; Roitberg S; Glotz D; Friedewald JJ; Leventhal JR
    Transplantation; 2014 Jul; 98(2):157-66. PubMed ID: 25003284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of amino acid mismatch in the UNOS dataset.
    Sasaki N; El-Awar N; Idica A
    Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA epitope matching in pediatric renal transplantation.
    Sypek MP; Hughes P; Kausman JY
    Pediatr Nephrol; 2017 Oct; 32(10):1861-1869. PubMed ID: 27995324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney allocation based on proven acceptable antigens results in superior graft survival in highly sensitized patients.
    Heidt S; Haasnoot GW; van Rood JJ; Witvliet MD; Claas FHJ
    Kidney Int; 2018 Feb; 93(2):491-500. PubMed ID: 28947279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matchmaker, matchmaker make me a match: Opportunities and challenges in optimizing compatibility of HLA eplets in transplantation.
    Lemieux W; Mohammadhassanzadeh H; Klement W; Daniel C; Sapir-Pichhadze R
    Int J Immunogenet; 2021 Apr; 48(2):135-144. PubMed ID: 33426788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class II Human Leukocyte Antigen Epitope Mismatch Predicts De Novo Donor-Specific Antibody Formation After Liver Transplantation.
    Kubal CA; Mangus R; Ekser B; Mihaylov P; Ceballos B; Higgins N; Chalasani N; Ghabril M; Nephew L; Lobashevsky A
    Liver Transpl; 2018 Aug; 24(8):1101-1108. PubMed ID: 30142248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are We Ready for Epitope-Based HLA Matching in Clinical Organ Transplantation?
    Duquesnoy RJ
    Transplantation; 2017 Aug; 101(8):1755-1765. PubMed ID: 28207632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.